Dialysate and substitution fluid quality for on-line haemodiafiltration and haemofiltration

Nephrology

Volumn 3, Issue 4, 1997, Pages 549-555

  Sato, Takashi ^a   Takamiya, Tomi ^b   Kim, Sung Teh ^a,f   Yamamoto, Chieko ^c   Fukui, Hiroyoshi ^d   Nakamoto, Masahiko ^e  

^a Koga Hospital   (Japan)

^b Seirankai Takamiya Hospital   (Japan)

^c Kitakyushu Institute of Biophysics   (Japan)

^d KUMAMOTO CHUO HOSPITAL   (Japan)

^e Saiseikai Yahata Hospital   (Japan)

^f Kitakyushu Nephro Clinic   (Japan)

Author keywords

Biocompatibility; Dialysate; Fever; Haemodiafiltration; Interleukin 6; On line haemodiafiltration; Safety; Standard; Substitution fluid; Tumour necrosis factor

Indexed keywords

DIALYSIS FLUID; ENDOTOXIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; BODY TEMPERATURE; CLINICAL TRIAL; DIALYSATE; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SAFETY;

EID: 0031406312     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00240.x     Document Type: Article

References (20)

1. Bardin T, Kuntz D, Zingraff J, Voisin MC, Zelmar A, Lansaman J. Synovial amyloidosis in patients undergoing long-term hemodialysis. Arthritis. Rheum. 1985; 28: 1051-8.
2. Munoz GJ, Bergada BE, Gomez PR et al. Amyloid arthropathy in patients undergoing periodical hemodialysis for chronic renal failure: A new complication. Ann. Rheum. Dis. 1985; 44: 729-33.
3. Brown EA, Arnold IR, Cower PE. Dialysis arthropathy: complication of long term treatment with haemodialysis. Br. Med. J. Clin. Res. Ed. 1986; 292: 163-6.
4. Maeda K, Kobayakawa H, Fujita Y et al. Effectiveness of push/pull hemodiafiltration using large-pore membrane for shoulder joint pain in long-term dialysis patients. Artif. Organs. 1990; 14: 321-7.
5. Malberti F, Surian M, Farina M et al. Effect of hemodialysis and hemodiafiltration on uremic neuropathy. Blood. Purif. 1991; 9: 285-95.
6. Henderson LW, Snfelippo ML, Beans E. On line preparation of sterile pyrogen-free electrolyte solution. Trans. Am. Soc. Artif. Intern. Organs 1978; 24: 465-7.
7. Shinzato T, Sezaki R, Usuda M, Ohbayashi S, Toyota T. Infusion-free hemodiafiltration: Simultaneous hemofiltration and dialysis with no need for infusion fluid. Artif. Organs. 1982; 6: 453-6.
8. Shaldon S, Beau MC, Deschodt G et al. Three years of experience with on-line preparation of sterile pyrogen-free infusate for haemofiltration. Contrib. Nephrol. 1982; 32: 161-4.
9. Canaud B, N'Guyen QV, Lagarde C, Stec F, Polaschegg HD, Mion C. Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for postdilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate. Contrib. Nephrol. 1985; 46: 184-6.
10. Mayr HU, Stec F, Mion CM. Standard methods for the microbiological assessment of electrolyte solution prepared on line for haemofiltration. Proc. Eur. Dial. Transplant. Assoc. Eur. Ren. Assoc. 1985; 21: 454-60.
11. Food and Drug Administration: Guideline on validation of the limulus amebocyte lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices. US Department of Health and Human Services, Public Health Service, Food and Drug Administration, 1987; 22-24.
12. Takamiya T. Efforts to reduce endotoxin levels in dialysate. Contrib. Nephrol. 1994; 108: 46-52.
13. Yamamoto C, Kim ST. Endotoxin rejection by ultrafiltration through high-flux, hollow fiber filters. J. Biomed. Mat. Res. 1996; 32: 467-71.
14. Kim ST. Characteristics of protein removal in hemodiafiltration. Contrib. Nephrol 1994; 108: 23-37.
15. Tanaka S, Iwanaga S. Limulus test for detecting bacterial endotoxins. Method. Enzymol. 1993; 223: 358-64.
16. Yamamoto C, Kim ST. Validation of lumulus tests for endotoxin evaluation in dialysate. Nephrology 1996; 2: 429-34.
17. Tamura H, Arimoto Y, Tanaka S, Yoshida M, Obayashi T, Kawai T. Automated kinetic assay for endotoxin and (1->3)-β-D-glucan in human blood. Clin. Chim. Acta. 1994; 226: 109-12.
18. Westphal O. Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture. Int. Arch. Allergy. Appl. Immunol. 1975; 49: 1-43.
19. Michie HR, Manogue KR, Spriggs DR et al. Detection of ciculating tumor becrosis factor after endotoxin administration. N. Engl. J. Med. 1988; 318: 1481-6.
20. Macdonald C, Rush DN, Bernstein KN, McKenna RM. Production of tumor necrosis factor alpha and hemodialysis. Nephron 1993; 65: 273-7.